glp 1 sleep apnea Therapeutic potential of GLP-1RAs in with genetic associations to type 2 diabetes | Diabetology & Metabolic Syndrome The pleiotropic effects of glucagon-like
Description
Christensen M., Vedtofte L., Holst J
Common side effects include nausea, constipation, and injection-site reactions
For most users, gastrointestinal side effects are most pronounced during the first few weeks and tend to improve as the body adjusts
This makes them particularly interesting for women who are overweight, have PCOS, or have diabetes and are preparing for pregnancy or fertility treatments
GLP-1 agonists have been shown to reduce binge-eating episodes, abnormal eating patterns, weight, and BMI (though BMI is a very flawed metric!)
